About this Journal Submit a Manuscript Table of Contents

Citations to this Journal [265 citations: 1–100 of 259 articles]

Articles published in International Journal of Breast Cancer have been cited 265 times. The following is a list of the 259 articles that have cited the articles published in International Journal of Breast Cancer.

  • Robert Schmadeka, and Bryan E. Harmon, “Triple-Negative Breast Carcinoma Current and Emerging Concepts,” American Journal of Clinical Pathology, vol. 141, no. 4, pp. 462–477, 2014. View at Publisher · View at Google Scholar
  • Ruichuan Chen, Jasper H. N. Yik, Qiao Jing Lew, and Sheng-Hao Chao, “Brd4 and HEXIM1: Multiple Roles in P-TEFb Regulation and Cancer,” BioMed Research International, vol. 2014, pp. 1–11, 2014. View at Publisher · View at Google Scholar
  • Isabel Fonseca, Sergio Dias, and J. C. Mendes de Almeida, “Plasma level of LDL-cholesterol at diagnosis is a predictor factor of breas t tumor progression,” Bmc Cancer, vol. 14, 2014. View at Publisher · View at Google Scholar
  • Heidi S. Wirtz, Denise M. Boudreau, Julie R. Gralow, William E. Barlow, Shelly Gray, Erin J. A. Bowles, and Diana S. M. Buist, “Factors associated with long-term adherence to annual surveillance mammography among breast cancer survivors,” Breast Cancer Research and Treatment, 2014. View at Publisher · View at Google Scholar
  • Candyce H. Kroenke, Carol Sweeney, Marilyn L. Kwan, Charles P. Quesenberry, Erin K. Weltzien, Laurel A. Habel, Adrienne Castillo, Phillip S. Bernard, Rachel E. Factor, Lawrence H. Kushi, and Bette J. Caan, “Race and breast cancer survival by intrinsic subtype based on PAM50 gene expression,” Breast Cancer Research and Treatment, 2014. View at Publisher · View at Google Scholar
  • Aneel Paulus, Kasyapa Chitta, Sharoon Akhtar, David Personett, Kena C. Miller, Kevin J. Thompson, Jennifer Carr, Shaji Kumar, Vivek Roy, Stephen M. Ansell, Joseph R. Mikhael, Angela Dispenzieri, Craig B. Reeder, Candido E. Rivera, and James Foran, “AT-101 downregulates BCL2 and MCL1 and potentiates the cytotoxic effects of lenalidomide and dexamethasone in preclinical models of multiple myeloma a nd Waldenstrom macroglobulinaemia,” British Journal of Haematology, vol. 164, no. 3, pp. 352–365, 2014. View at Publisher · View at Google Scholar
  • Maria Gere, Miklos Tarjan, Dan Hellberg, and Tibor Tot, “Molecular Phenotype of the Foci in Multifocal Invasive Breast Carcinomas,” Cancer, vol. 120, no. 1, pp. 26–34, 2014. View at Publisher · View at Google Scholar
  • Rainer J. Klement, and Colin E. Champ, “Calories, carbohydrates, and cancer therapy with radiation: exploiting the five R’s through dietary manipulation,” Cancer and Metastasis Reviews, 2014. View at Publisher · View at Google Scholar
  • Michael Scully, Gloria Petralia, and Ajay Kakkar, “Binding and inhibition of drug transport proteins by heparin A potential dr ug transporter modulator capable of reducing multidrug resistance in human cancer cells,” Cancer Biology & Therapy, vol. 15, no. 1, pp. 135–145, 2014. View at Publisher · View at Google Scholar
  • Witold Lasek, Radosław Zagożdżon, and Marek Jakobisiak, “Interleukin 12: still a promising candidate for tumor immunotherapy?,” Cancer Immunology, Immunotherapy, 2014. View at Publisher · View at Google Scholar
  • Y. Rebecca Chin, Taku Yoshida, Andriy Marusyk, Andrew H. Beck, and Kornelia Polyak, “Targeting Akt3 Signaling in Triple-Negative Breast Cancer,” Cancer Research, vol. 74, no. 3, pp. 964–973, 2014. View at Publisher · View at Google Scholar
  • Chun Wang, Can-Xin Xu, Yiwen Bu, and Kathleen M. Bottum, “Beta-naphthoflavone (DB06732) mediates estrogen receptor-positive breast ca ncer cell cycle arrest through AhR-dependent regulation of PI3K/AKT and MAP K/ERK signaling,” Carcinogenesis, vol. 35, no. 3, pp. 703–713, 2014. View at Publisher · View at Google Scholar
  • Anna Paszel-Jaworska, Barbara Bednarczyk-Cwynar, Lucjusz Zaprutko, Mariusz Kaczmarek, and Maria Rybczynska, “Methyl 3-hydroxyimino-11-oxoolean-12-en-28-oate (HIMOXOL), a synthetic olea nolic acid derivative, induces both apoptosis and autophagy in MDA-MB-231 b reast cancer cells,” Chemico-Biological Interactions, vol. 208, pp. 47–57, 2014. View at Publisher · View at Google Scholar
  • Suet M. Chan, Vivien Ng, Brendan M. Smith, Hilary Umeh, and Stephen P. Courtney, “Risk Stratification of Patients With Early Breast Cancer,” Clinical Breast Cancer, vol. 14, no. 1, pp. 68–73, 2014. View at Publisher · View at Google Scholar
  • Lisa L. Ferguson, Britne Curran, Mary Martinez, and Peggy Mancuso, “Triple-Negative Breast Cancer: What Is Known About It?,” Clinical Journal of Oncology Nursing, vol. 18, no. 1, pp. E6–E11, 2014. View at Publisher · View at Google Scholar
  • Lee Khuan, Halimatun Halaliah Mokhtar, Steven Eric Krauss, and Ong Beng Kok, “Hypertensive patients' preferences for complementary and alternative medicine and the influence of these preferences on the adherence to prescribed medication,” Complementary Therapies in Clinical Practice, 2014. View at Publisher · View at Google Scholar
  • Demetrios Simos, Mark Clemons, Ophira M. Ginsburg, and Carmel Jacobs, “Definition and consequences of locally advanced breast cancer,” Current Opinion in Supportive and Palliative Care, vol. 8, no. 1, pp. 33–38, 2014. View at Publisher · View at Google Scholar
  • Mark Clemons, Carmel Jacobs, and Demetrios Simos, “Treatment for locally advanced breast cancer,” Current Opinion in Supportive and Palliative Care, vol. 8, no. 1, pp. 30–32, 2014. View at Publisher · View at Google Scholar
  • Carlos Eduardo Coral de Oliveira, Julie Massayo Maeda Oda, Roberta Losi Guembarovski, Karen Brajão de Oliveira, Carolina Batista Ariza, Jamil Soni Neto, Bruna Karina Banin Hirata, and Maria Angelica Ehara Watanabe, “CC Chemokine Receptor 5: The Interface of Host Immunity and Cancer,” Disease Markers, vol. 2014, pp. 1–8, 2014. View at Publisher · View at Google Scholar
  • Tibor Tot, James Going, Maria Pia Foschini, Gyula Pekar, Lee Tucker, and Anna Sapino, “E04. Balancing between classic morphology and molecular medicine,” European Journal of Cancer, vol. 50, pp. S8–S9, 2014. View at Publisher · View at Google Scholar
  • Ahmed I. Foudah, Asmaa A. Sallam, and Mohamed R. Akl, “Optimization, pharmacophore modeling and 3D-QSAR studies of sipholanes as b reast cancer migration and proliferation inhibitors,” European Journal of Medicinal Chemistry, vol. 73, pp. 310–324, 2014. View at Publisher · View at Google Scholar
  • Winnie K.W. So, Ka Ming Chow, Helen Y.L. Chan, Kai Chow Choi, Rayman W.M. Wan, Suzanne S.S. Mak, Sek Ying Chair, and Carmen W.H. Chan, “Quality of life and most prevalent unmet needs of Chinese breast cancer survivors at one year after cancer treatment,” European Journal of Oncology Nursing, 2014. View at Publisher · View at Google Scholar
  • Donna D'Alessio, Laura Liberman, Dilip Giri, Edi Brogi, and Elizabeth A. Morris, “Cancelled stereotactic biopsy of calcifications not seen using the stereota ctic technique: do we still need to biopsy?,” European Radiology, vol. 24, no. 4, pp. 907–912, 2014. View at Publisher · View at Google Scholar
  • Nadia Harbeck, Flavio Solca, and Thomas C Gauler, “Preclinical and clinical development of afatinib: a focus on breast cancer and squamous cell carcinoma of the head and neck,” Future Oncology, vol. 10, no. 1, pp. 21–40, 2014. View at Publisher · View at Google Scholar
  • Joshua G. Cohen, Arthur-Quan Tran, B.J. Rimel, Ilana Cass, Christine S. Walsh, Beth Y. Karlan, and Andrew J. Li, “Thrombocytosis at secondary cytoreduction for recurrent ovarian cancer predicts suboptimal resection and poor survival,” Gynecologic Oncology, 2014. View at Publisher · View at Google Scholar
  • Angela de Maggio da Fonseca, Vicente Renato Bagnoli, Nestor de Barros, Erica Mendonca das Neves, Sandra Dircinha Teixeira de Araujo Moraes, Victor Hugo Souza Hortense, Jose Maria Soares, and Edmund Chada Baracat, “The expression of the estrogen receptor in obese patients with high breast density (HBD),” Gynecological Endocrinology, vol. 30, no. 1, pp. 78–80, 2014. View at Publisher · View at Google Scholar
  • Zaibo Li, Oluwole Fadare, Omar Hameed, and Chengquan Zhao, “Incidental atypical proliferative lesions in reduction mammoplasty specimen s in patients with a history of breast cancer,” Human Pathology, vol. 45, no. 1, pp. 104–109, 2014. View at Publisher · View at Google Scholar
  • Fathollah Tahmasebi, Tohid Kazemi, Mohammad Mehdi Amiri, Jalal Khoshnoodi, Jafar Mahmoudian, Ali Ahmad Bayat, Mahmood Jeddi-Tehrani, and Hodjatallah Rabbani, “In vitro assessment of the effects of anti-HER2 monoclonal antibodies on pr oliferation of HER2-overexpressing breast cancer cells,” Immunotherapy, vol. 6, no. 1, pp. 43–49, 2014. View at Publisher · View at Google Scholar
  • Michael Dinwiddie, Paul Terry, and Jiangang Chen, “Recent Evidence Regarding Triclosan and Cancer Risk,” International Journal of Environmental Research and Public Health, vol. 11, no. 2, pp. 2209–2217, 2014. View at Publisher · View at Google Scholar
  • Jing Li, Chunquan Li, Junwei Han, Chunlong Zhang, Desi Shang, Qianlan Yao, Yunpeng Zhang, Yanjun Xu, Wei Liu, Meng Zhou, Haixiu Yang, Fei Su, and Xia Li, “The detection of risk pathways, regulated by miRNAs, via the integration of sample-matched miRNA-mRNA profiles and pathway structure,” Journal of Biomedical Informatics, 2014. View at Publisher · View at Google Scholar
  • Venkatesh Krishnan, Erwin A. Vogler, and Donna M. Sosnoski, “In Vitro Mimics of Bone Remodeling and the Vicious Cycle of Cancer in Bone,” Journal of Cellular Physiology, vol. 229, no. 4, pp. 453–462, 2014. View at Publisher · View at Google Scholar
  • Abbey J. Winant, and Syed A. Hoda, “Cystic apocrine hyperplasia is the most common finding in MRI detected brea st lesions,” Journal of Clinical Pathology, vol. 67, no. 2, pp. 182–186, 2014. View at Publisher · View at Google Scholar
  • Edgar C. Ontsouka, and Christiane Albrecht, “Cholesterol Transport and Regulation in the Mammary Gland,” Journal of Mammary Gland Biology and Neoplasia, 2014. View at Publisher · View at Google Scholar
  • Colin E. Champ, Joshua D. Palmer, Jeff S. Volek, Maria Werner-Wasik, David W. Andrews, James J. Evans, Jon Glass, Lyndon Kim, and Wenyin Shi, “Targeting metabolism with a ketogenic diet during the treatment of glioblastoma multiforme,” Journal of Neuro-Oncology, 2014. View at Publisher · View at Google Scholar
  • Yavuz Kececi, Funda Alkan Tasli, Ayse Yagcı, Emin Sır, Selin Canpolat, and Enver Vardar, “Histopathologic findings in breast reduction specimens,” Journal of Plastic Surgery and Hand Surgery, vol. 48, no. 2, pp. 122–125, 2014. View at Publisher · View at Google Scholar
  • Rachel N. Goble, Jennifer S. Drukteinis, M. Catherine Lee, Nazanin Khakpour, John V. Kiluk, and Christine Laronga, “Early experience with ultrasound features after intrabeam intraoperative radiation for early stage breast cancer,” Journal of Surgical Oncology, 2014. View at Publisher · View at Google Scholar
  • Shereef Elsamany, and Sakher Abdullah, “Triple-negative breast cancer: future prospects in diagnosis and management,” Medical Oncology, vol. 31, no. 2, 2014. View at Publisher · View at Google Scholar
  • Sagar Ghosh, Daniel Hughes, Dorothy Long Parma, Amelie Ramirez, and Rong Li, “Association of obesity and circulating adipose stromal cells among breast cancer survivors,” Molecular Biology Reports, 2014. View at Publisher · View at Google Scholar
  • Padmanaban S. Suresh, Shao Ma, and Antimo Migliaccio, “Protein-Tyrosine Phosphatase H1 Increases Breast Cancer Sensitivity to Anti estrogens by Dephosphorylating Estrogen Receptor at Tyr537,” Molecular Cancer Therapeutics, vol. 13, no. 1, pp. 230–238, 2014. View at Publisher · View at Google Scholar
  • Mridul Chowdhury, Wei Wu, M. D. Touhidul Imran Chowdhury, Bidhan Chandra Pal, Rifat Hasan, Zahid H. Khan, Dali Dutta, Arif Abu Saeem, Raiyan Al-Mansur, Sahin Mahmud, James H. Woods, Heather H. Story, and Reza Salim, “An mHealth Model to Increase Clinic Attendance for Breast Symptoms in Rural Bangladesh: Can Bridging the Digital Divide Help Close the Cancer Divide?,” Oncologist, vol. 19, no. 2, pp. 177–185, 2014. View at Publisher · View at Google Scholar
  • Milou S.C. Sep, Mara van Osch, Liesbeth M. van Vliet, Ellen M.A. Smets, and Jozien M. Bensing, “The power of clinicians’ affective communication: How reassurance about non-abandonment can reduce patients’ physiological arousal and increase information recall in bad news consultations. An experimental study using analogue patients,” Patient Education and Counseling, 2014. View at Publisher · View at Google Scholar
  • Laura Poillet, Nicolas Pernodet, Michael Boyer-Guittaut, Pascale Adami, Christophe Borg, Michele Jouvenot, and Regis Delage-Mourroux, “QSOX1 Inhibits Autophagic Flux in Breast Cancer Cells,” Plos One, vol. 9, no. 1, 2014. View at Publisher · View at Google Scholar
  • Bertrand De Meulder, Fabrice Berger, Eric Bareke, Sophie Depiereux, and Carine Michiels, “Meta-Analysis and Gene Set Analysis of Archived Microarrays Suggest Implica tion of the Spliceosome in Metastatic and Hypoxic Phenotypes,” Plos One, vol. 9, no. 1, 2014. View at Publisher · View at Google Scholar
  • Ming Shi, Yuanfei Yao, Fang Han, and Yiqun Li, “MAP1S Controls Breast Cancer Cell TLR5 Signaling Pathway and Promotes TLR5 Signaling-based Tumor Suppression,” Plos One, vol. 9, no. 1, 2014. View at Publisher · View at Google Scholar
  • Prathap Kumar S. Mahalingaiah, “Chronic Oxidative Stress Increases Growth and Tumorigenic Potential of MCF- 7 Breast Cancer Cells,” Plos One, vol. 9, no. 1, 2014. View at Publisher · View at Google Scholar
  • Ahmed A. Mostafa, Dianne Codner, Kensuke Hirasawa, Yumiko Komatsu, Matthew N. Young, and Viktor Steimle, “Activation of ER alpha Signaling Differentially Modulates IFN-gamma Induced HLA-Class II Expression in Breast Cancer Cells,” Plos One, vol. 9, no. 1, 2014. View at Publisher · View at Google Scholar
  • Abhita Malaviya, and Paul W. Sylvester, “Synergistic Antiproliferative Effects of Combined γ-Tocotrienol and PPARγ Antagonist Treatment Are Mediated through PPARγ-Independent Mechanisms in Breast Cancer Cells,” PPAR Research, vol. 2014, pp. 1–18, 2014. View at Publisher · View at Google Scholar
  • Yu Jin Lim, Kyubo Kim, Eui Kyu Chie, Wonshik Han, Dong Young Noh, and Sung W. Ha, “ Treatment outcome of ductal carcinoma in situ patients treated with postoperative radiation therapy ,” Radiation Oncology Journal, vol. 32, no. 1, pp. 1, 2014. View at Publisher · View at Google Scholar
  • M. Kamil Hussain, M. Imran Ansari, N. Yadav, Puneet K. Gupta, A. K. Saxena, K. Hajela, J. Gautam, Ruchir Kant, P. R. Maulik, R. Trivedi, A. Dwivedi, K. Ravi Kumar, A. K. Gupta, R. Saxena, I. Fatima, M. Manohar, P. Kushwaha, and V. Khedgikar, “Design and synthesis of ERα/ERβ selective coumarin and chromene derivatives as potential anti-breast cancer and anti-osteoporotic agents,” RSC Advances, vol. 4, no. 17, pp. 8828, 2014. View at Publisher · View at Google Scholar
  • Zhaoqi Liu, Xiang-Sun Zhang, and Shihua Zhang, “Breast tumor subgroups reveal diverse clinical prognostic power,” Scientific Reports, vol. 4, 2014. View at Publisher · View at Google Scholar
  • Chafika Mazouni, Jacqueline Deneuve, Monica Arnedos, Fanny Prenois, Mahasti Saghatchian, Fabrice André, Céline Bourgier, and Suzette Delaloge, “Decision-making from multidisciplinary team meetings to the bedside: Factors influencing the recruitment of breast cancer patients into clinical trials,” The Breast, 2014. View at Publisher · View at Google Scholar
  • Elzbieta Senkus, “Breast cancer units – Improvement in care or expensive “wishful thinking”?,” The Breast, 2014. View at Publisher · View at Google Scholar
  • Yan Chen, Zheng Li, Yan He, Dandan Shang, Jigang Pan, Hongmei Wang, Huamei Chen, Zhuxia Zhu, Lei Wan, and Xudong Wang, “Estrogen and pure antiestrogen fulvestrant (ICI 182 780) augment cell- matrigel adhesion of MCF-7 breast cancer cells through a novel G protein coupled estrogen receptor (GPR30)-to-calpain signaling axis,” Toxicology and Applied Pharmacology, 2014. View at Publisher · View at Google Scholar
  • Se Young Park, Hyung Jeong Kim, Ki Rim Kim, Sun Kyoung Lee, Chang Ki Lee, Kwang-Kyun Park, and Won-Yoon Chung, “Betulinic acid, a bioactive pentacyclic triterpenoid, inhibits skeletal-related events induced by breast cancer bone metastases and treatment,” Toxicology and Applied Pharmacology, 2014. View at Publisher · View at Google Scholar
  • Olfa Baroudi, Nadia Kourda, Yves-Jean Bignon, Nancy Uhrhammer, Alexis Desrichard, Imen Medimegh, Hager Ayari, Nejla Stambouli, Amel Mezlini, Hssan Bouzayenne, Raja Marrakchi, Amel Benammar-Elgaaid, and Karim Bougatef, “Positive link between variant Toll-like receptor 4 (Asp299Gly and Thr399Ile ) and colorectal cancer patients with advanced stage and lymph node metasta sis,” Tumor Biology, vol. 35, no. 1, pp. 545–551, 2014. View at Publisher · View at Google Scholar
  • Subhas C. Kundu, “Engineered 3D Silk-Based Metastasis Models: Interactions Between Human Brea st Adenocarcinoma, Mesenchymal Stem Cells and Osteoblast-Like Cells,” Advanced Functional Materials, vol. 23, no. 42, pp. 5249–5260, 2013. View at Publisher · View at Google Scholar
  • Atileombolo A. Lotika, Langalibalele H. Mabuza, and Henry I. Okonta, “Reasons given by hypertensive patients for concurrently using traditional and Western medicine at Natalspruit Hospital in the Gauteng Province, South Africa,” African Journal of Primary Health Care & Family Medicine, vol. 5, no. 1, 2013. View at Publisher · View at Google Scholar
  • Edwin A. Higuita, Fabian A. Jaimes, Maria T. Rugeles, and Carlos J. Montoya, “In vivo effect of statins on the expression of the HIV co-receptors CCR5 an d CXCR4,” Aids Research and Therapy, vol. 10, 2013. View at Publisher · View at Google Scholar
  • Nasir Ud Din, Romana Idrees, Saira Fatima, and Naila Kayani, “Secretory carcinoma of breast: clinicopathologic study of 8 cases,” Annals of Diagnostic Pathology, vol. 17, no. 1, pp. 54–57, 2013. View at Publisher · View at Google Scholar
  • T. M. A. Abdel-Fatah, C. Perry, P. Dickinson, G. Ball, P. Moseley, S. Madhusudan, and I. O. Ellis, “Bcl2 is an independent prognostic marker of triple negative breast cancer ( TNBC) and predicts response to anthracycline combination (ATC) chemotherapy (CT) in adjuvant and neoadjuvant settings,” Annals of Oncology, vol. 24, no. 11, pp. 2801–2807, 2013. View at Publisher · View at Google Scholar
  • T. Kirchhoff, “Introduction to epidemiology of breast and ovarian cancers,” Annals of Oncology, vol. 24, pp. 61–62, 2013. View at Publisher · View at Google Scholar
  • T. de Vin, B. Engels, T. Gevaert, G. Storme, and M. De Ridder, “Stereotactic radiotherapy for oligometastatic cancer: a prognostic model for survival,” Annals of Oncology, 2013. View at Publisher · View at Google Scholar
  • Penelope E. Schofield, G. Bruce Mann, and Karla Gough, “Profile and Predictors of Long-term Morbidity in Breast Cancer Survivors,” Annals Of Surgical Oncology, vol. 20, no. 11, pp. 3453–3460, 2013. View at Publisher · View at Google Scholar
  • Geraldine Rauch, Akos Z. Szabo, Carlos A. Garcia-Etienne, Michael Golatta, Christoph Domschke, Mahyar Badiian, Peter Kern, Florian Schuetz, Markus Wallwiener, Christof Sohn, Hubertus Fries, Gunter von Minckwitz, Andreas Schneeweiss, and Mahdi Rezai, “Breast Cancer Mastectomy Trends Between 2006 and 2010: Association with Mag netic Resonance Imaging, Immediate Breast Reconstruction, and Hospital Volu me,” Annals of Surgical Oncology, vol. 20, no. 12, pp. 3839–3846, 2013. View at Publisher · View at Google Scholar
  • N. Eiro, C. Ovies, B. Fernandez-Garcia, C. C. Alvarez-Cuesta, L. Gonzalez, L. O. Gonzalez, and F. J. Vizoso, “Expression of TLR3, 4, 7 and 9 in cutaneous malignant melanoma: relationshi p with clinicopathological characteristics and prognosis,” Archives of Dermatological Research, vol. 305, no. 1, pp. 59–67, 2013. View at Publisher · View at Google Scholar
  • Zohreh Sanaat, Iraj Asvadi, Saeed Dastgiri, Jalil Vaez, and Ali Pourzand, “Survival Analysis of Breast Cancer Patients in Northwest Iran,” Asian Pacific Journal Of Cancer Prevention, vol. 14, no. 1, pp. 39–42, 2013. View at Publisher · View at Google Scholar
  • Qing Hu, Wei-Xian Chen, Shan-Liang Zhong, Jian Li, Zhou Luo, and Jian-Hua Zhao, “Current Progress in the Treatment of Metaplastic Breast Carcinoma,” Asian Pacific Journal of Cancer Prevention, vol. 14, no. 11, pp. 6221–6225, 2013. View at Publisher · View at Google Scholar
  • Rabail Nasir, and Mohd Nor Norazmi, “Influence of 17 beta-Estradiol on 15-Deoxy-Delta(12,14)Prostaglandin J(2)-I nduced Apoptosis in MCF-7 and MDA-MB-231 Cells,” Asian Pacific Journal of Cancer Prevention, vol. 14, no. 11, pp. 6761–6767, 2013. View at Publisher · View at Google Scholar
  • Khatijah Lim Abdullah, Cheng Har Yip, Soo-Hwang Teo, Nur Aishah Taib, and Chirk Jenn Ng, “The Decision-Making Journey of Malaysian Women with Early Breast Cancer: A Qualitative Study,” Asian Pacific Journal of Cancer Prevention, vol. 14, no. 12, pp. 7143–7147, 2013. View at Publisher · View at Google Scholar
  • Ahad Muhammadnejad, Farkhondeh Behjati, Fereidoon Sirati, Faranak Khodadadi, Masoud Karimlou, Fatemeh A. Moghaddam, and Reza Pazhoomand, “Angiogenesis Markers in Breast Cancer - Potentially Useful Tools for Priori ty Setting of Anti-Angiogenic Agents,” Asian Pacific Journal of Cancer Prevention, vol. 14, no. 12, pp. 7651–7656, 2013. View at Publisher · View at Google Scholar
  • Imi Sairi Ab Hadi, Zainal Mahamood, Zulkifli Ahmad, and Soon Lean Keng, “Understanding the Breast Cancer Experience: a Qualitative Study of Malaysia n Women,” Asian Pacific Journal of Cancer Prevention, vol. 14, no. 6, pp. 3689–3698, 2013. View at Publisher · View at Google Scholar
  • Chun-Yan Li, Sheng Zhang, Xiao-Bei Zhang, Pei Wang, and Guo-Fang Hou, “Clinicopathological and Prognostic Characteristics of Triple-Negative Breas t Cancer (TNBC) in Chinese Patients: A Retrospective Study,” Asian Pacific Journal of Cancer Prevention, vol. 14, no. 6, pp. 3779–3784, 2013. View at Publisher · View at Google Scholar
  • Xiao-Pan Li, Zhen-Yu Xie, Yi-Fei Fu, Chen Yang, Li-Peng Hao, Li-Ming Yang, Mei-Yu Zhang, Xiao-Li Li, Li-Li Feng, and Bei Yan, “Colorectal Cancer Concealment Predicts a Poor Survival: A Retrospective Stu dy,” Asian Pacific Journal of Cancer Prevention, vol. 14, no. 7, pp. 4157–4160, 2013. View at Publisher · View at Google Scholar
  • Jun Long, Xulong Zhang, Mingjie Wen, Qingli Kong, Zhe Lv, Yunqing An, and Xiao-Qing Wei, “IL-35 over-expression increases apoptosis sensitivity and suppresses cell growth in human cancer cells,” Biochemical and Biophysical Research Communications, vol. 430, no. 1, pp. 364–369, 2013. View at Publisher · View at Google Scholar
  • David P. Rose, and Linda Vona-Davis, “Biochemical and molecular mechanisms for the association between obesity, chronic Inflammation, and breast cancer,” BioFactors, vol. 40, no. 1, pp. 1–12, 2013. View at Publisher · View at Google Scholar
  • Paul W. Sylvester, Mohamed R. Akl, Abhita Malaviya, Parash Parajuli, Suryatheja Ananthula, Roshan V. Tiwari, and Nehad M. Ayoub, “Potential role of tocotrienols in the treatment and prevention of breast cancer,” BioFactors, 2013. View at Publisher · View at Google Scholar
  • Simon Fong, Yang Zhang, Jinan Fiaidhi, Osama Mohammed, and Sabah Mohammed, “Evaluation of Stream Mining Classifiers for Real-Time Clinical Decision Support System: A Case Study of Blood Glucose Prediction in Diabetes Therapy,” BioMed Research International, vol. 2013, pp. 1–16, 2013. View at Publisher · View at Google Scholar
  • V. L. Battula, Y. Chen, M. d. G. Cabreira, V. Ruvolo, Z. Wang, W. Ma, S. Konoplev, E. Shpall, K. Lyons, D. Strunk, C. Bueso-Ramos, R. E. Davis, M. Konopleva, and M. Andreeff, “Connective tissue growth factor regulates adipocyte differentiation of mesenchymal stromal cells and facilitates leukemia bone marrow engraftment,” Blood, vol. 122, no. 3, pp. 357–366, 2013. View at Publisher · View at Google Scholar
  • Anna Crispo, Maddalena Barba, Giuseppe D'Aiuto, Michelino De Laurentiis, Maria Grimaldi, Massimo Rinaldo, Giuseppina Caolo, Massimiliano D'Aiuto, Immacolata Capasso, Emanuela Esposito, Alfonso Amore, Maurizio Di Bonito, Gerardo Botti, and Maurizio Montella, “Molecular profiles of screen detected vs. symptomatic breast cancer and the ir impact on survival: results from a clinical series,” Bmc Cancer, vol. 13, 2013. View at Publisher · View at Google Scholar
  • Mei-Chi Hsu, Kuo-Ting Lee, Wei-Chiang Hsiao, Chih-Hsing Wu, Hung-Yu Sun, I-Ling Lin, and Kung-Chia Young, “The dyslipidemia-associated SNP on the APOA1/C3/A5 gene cluster predicts post-surgery poor outcome in Taiwanese breast cancer patients: a 10-year follow-up study,” BMC Cancer, vol. 13, no. 1, pp. 330, 2013. View at Publisher · View at Google Scholar
  • Nathan C. Hall, “Recognizing the role of surgical oncology and cancer imaging in the multidi sciplinary approach to cancer: an important area of future scholarly growth for BMC Cancer,” Bmc Cancer, vol. 13, 2013. View at Publisher · View at Google Scholar
  • Aram S. A. van Brussel, Jeroen F. Vermeulen, Willem P. Th M. Mali, Elsken van der Wall, Paul J. van Diest, and Sjoerd G. Elias, “The potential of hypoxia markers as target for breast molecular imaging - a systematic review and meta-analysis of human marker expression,” Bmc Cancer, vol. 13, 2013. View at Publisher · View at Google Scholar
  • Georgia Mode Magalhaes, Rosemeri de Oliveira Vasconcelos, Marcio de Barros Bandarra, Pamela Rodrigues Reina Moreira, Mayara Caroline Rosolem, and Antonio Carlos Alessi, “Immunodetection of cells with a CD44+/CD24-phenotype in canine mammary neop lasms,” Bmc Veterinary Research, vol. 9, 2013. View at Publisher · View at Google Scholar
  • G. Cserni, R. Bori, I. Sejben, A. Voeroes, L. Kaiser, S. Hamar, E. Csoergo, and J. Kulka, “Unifocal, multifocal and diffuse carcinomas: A reproducibility study of bre ast cancer distribution,” Breast, vol. 22, no. 1, pp. 34–38, 2013. View at Publisher · View at Google Scholar
  • Abraham Kuten, Christine Lai, and Orit Kaidar-Person, “"The Infinite Maze" of breast cancer, signaling pathways and radioresistanc e,” Breast, vol. 22, no. 4, pp. 411–418, 2013. View at Publisher · View at Google Scholar
  • Roxana Chiorean, and Ioana Berindan-Neagoe, “Another review on triple negative breast cancer. Are we on the right way to wards the exit from the labyrinth?,” Breast, vol. 22, no. 6, pp. 1026–1033, 2013. View at Publisher · View at Google Scholar
  • Masakuni Noguchi, Emi Morioka, Yukako Ohno, Miki Noguchi, Yasuharu Nakano, and Takeo Kosaka, “The changing role of axillary lymph node dissection for breast cancer,” Breast Cancer, vol. 20, no. 1, pp. 41–46, 2013. View at Publisher · View at Google Scholar
  • Rakesh K. Singh, “Animal model for mammary tumor growth in the bone microenvironment,” Breast Cancer, vol. 20, no. 3, pp. 195–203, 2013. View at Publisher · View at Google Scholar
  • Fikri İçli, Kadri Altundağ, Hakan Akbulut, Semra Paydaş, Gül Başaran, Pınar Saip, Gamze G. Doğu, Yeşim Eralp, Rüçhan Uslu, Alper Sevinç, Handan Onur, Nil M. Mandel, Canfeza Sezgin, Mustafa Altınbaş, Nilüfer Güler, Abdurrahman Işıkdoğan, Erhan Gökmen, Kazım Uygun, Zeki Üstüner, Arzu Yaren, Binnaz Demirkan, Uğur Coşkun, Alper Ata, Metin Özkan, and Ali Arican, “Nine weeks versus 1 year adjuvant trastuzumab in patients with early breast cancer: an observational study by the Turkish Oncology Group (TOG),” Breast Cancer, 2013. View at Publisher · View at Google Scholar
  • Lopamudra Das Roy, Jennifer M. Curry, Mahnaz Sahraei, Dahlia M. Besmer, Amritha Kidiyoor, and Helen E. Gruber, “Arthritis augments breast cancer metastasis: role of mast cells and SCF/c-K it signaling,” Breast Cancer Research, vol. 15, no. 2, 2013. View at Publisher · View at Google Scholar
  • Eric O. Aboagye, Simak Ali, Annie S. Anderson, Jo Armes, Fedor Berditchevski, Jeremy P. Blaydes, Keith Brennan, Nicola J. Brown, Helen E. Bryant, Nigel J. Bundred, Joy M. Burchell, Anna M. Campbell, Jason S. Carroll, Robert B. Clarke, Charlotte E. Coles, Gary J. R. Cook, Angela Cox, Nicola J. Curtin, Lodewijk V. Dekker, Isabel dos Santos Silva, Stephen W. Duffy, Douglas F. Easton, Diana M. Eccles, Dylan R. Edwards, Joanne Edwards, D. Gareth Evans, Deborah F. Fenlon, James M. Flanagan, Claire Foster, William M. Gallagher, Montserrat Garcia-Closas, Julia M. W. Gee, Andy J. Gescher, Vicky Goh, Ashley M. Groves, Amanda J. Harvey, Michelle Harvie, Bryan T. Hennessy, Stephen Hiscox, Ingunn Holen, Sacha J. Howell, Anthony Howell, Gill Hubbard, Nick Hulbert-Williams, Myra S. Hunter, Bharat Jasani, Louise J. Jones, Timothy J. Key, Cliona C. Kirwan, Anthony Kong, Ian H. Kunkler, Simon P. Langdon, Martin O. Leach, David J. Mann, John F. Marshall, Lesley Ann Martin, Stewart G. Martin, Jennifer E. Macdougall, David W. Miles, William R. Miller, Joanna R. Morris, Sue M. Moss, Paul Mullan, Rachel Natrajan, James P. B. O'Connor, Rosemary O'Connor, Carlo Palmieri, Paul D. P. Pharoah, Emad A. Rakha, Elizabeth Reed, Simon P. Robinson, Erik Sahai, John M. Saxton, Peter Schmid, Matthew J. Smalley, Valerie Speirs, Robert Stein, John Stingl, Charles H. Streuli, Andrew N. J. Tutt, Galina Velikova, Rosemary A. Walker, Christine J. Watson, Kaye J. Williams, Leonie S. Young, and Alastair M. Thompson, “Critical research gaps and translational priorities for the successful prev ention and treatment of breast cancer,” Breast Cancer Research, vol. 15, no. 5, 2013. View at Publisher · View at Google Scholar
  • Yun-Ju Chen, Ming-Hsin Yeh, Meng-Chieh Yu, Ya-Ling Wei, Wen-Shu Chen, Jhen-Yu Chen, Chih-Yu Shih, Chih-Yen Tu, Chia-Hung Chen, Te-Chun Hsia, Pei-Hsuan Chien, Shu-Hui Liu, and Yung-Luen Yu, “Lapatinib-induced NF-kappaB activation sensitizes triple-negative breast ca ncer cells to proteasome inhibitors,” Breast Cancer Research, vol. 15, no. 6, 2013. View at Publisher · View at Google Scholar
  • Jonas Wolf, Dyah Laksmi Dewi, Johannes Fredebohm, Karin Mueller-Decker, Christa Flechtenmacher, and Joerg D. Hoheisel, “A mammosphere formation RNAi screen reveals that ATG4A promotes a breast ca ncer stem-like phenotype,” Breast Cancer Research, vol. 15, no. 6, 2013. View at Publisher · View at Google Scholar
  • Jose M. Pacheco, Feng Gao, Caroline Bumb, Matthew J. Ellis, and Cynthia X. Ma, “Racial differences in outcomes of triple-negative breast cancer,” Breast Cancer Research and Treatment, vol. 138, no. 1, pp. 281–289, 2013. View at Publisher · View at Google Scholar
  • Susan E. McCann, Stephen B. Edge, Christine B. Ambrosone, Lei Quan, Elizabeth A. Repasky, Song Yao, Ree Y. Dolnick, Sharon S. Evans, Paul K. Wallace, Zhihong Gong, and Kelvin P. Lee, “Pretreatment levels of circulating Th1 and Th2 cytokines, and their ratios, are associated with ER-negative and triple negative breast cancers,” Breast Cancer Research And Treatment, vol. 139, no. 2, pp. 477–488, 2013. View at Publisher · View at Google Scholar
  • Mark E. Robson, Carmen A. Perez, Zachary S. Zumsteg, Gaorav Gupta, Tiffany A. Traina, Yong H. Wen, Brittany Arnold, Beryl McCormick, Simon N. Powell, Monica Morrow, and Sujata M. Patil, “Black race as a prognostic factor in triple-negative breast cancer patients treated with breast-conserving therapy: a large, single-institution retros pective analysis,” Breast Cancer Research And Treatment, vol. 139, no. 2, pp. 497–506, 2013. View at Publisher · View at Google Scholar
  • Florence Dalenc, Mario Campone, Ruth M. O'Regan, Vivianne C. Tjan-Heijnen, Joseph Gligorov, Antonio Llombart, Haresh Jhangiani, Hamid R. Mirshahidi, Elizabeth Tan-Chiu, Sara Miao, Mona El-Hashimy, Jeremie Lincy, Tetiana Taran, Jean-Charles Soria, Tarek Sahmoud, and Fabrice Andre, “A phase 2 study of everolimus combined with trastuzumab and paclitaxel in p atients with HER2-overexpressing advanced breast cancer that progressed dur ing prior trastuzumab and taxane therapy,” Breast Cancer Research and Treatment, vol. 141, no. 3, pp. 437–446, 2013. View at Publisher · View at Google Scholar
  • Sneha Sundaram, Alex J. Freemerman, Amy R. Johnson, J. Justin Milner, Kirk K. McNaughton, Joseph A. Galanko, Katharine M. Bendt, David B. Darr, Charles M. Perou, Melissa A. Troester, and Liza Makowski, “Role of HGF in obesity-associated tumorigenesis: C3(1)-TAg mice as a model for human basal-like breast cancer,” Breast Cancer Research and Treatment, 2013. View at Publisher · View at Google Scholar
  • Monika Eichholzer, Alexandra Modlasiak, Andreas Schoetzau, Sabine Rohrmann, Dorothy J. Huang, and Seraina M. Schmid, “Impact of Body Mass Index on Prognostically Relevant Breast Cancer Tumor Ch aracteristics,” Breast Care, vol. 8, no. 3, pp. 192–198, 2013. View at Publisher · View at Google Scholar
  • S. Swartzman, “What is a virtual multidisciplinary team (vMDT)?,” British Journal Of Cancer, vol. 108, no. 12, pp. 2433–2441, 2013. View at Publisher · View at Google Scholar